132 related articles for article (PubMed ID: 28089742)
21. A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci.
Tsilchorozidou T; Vafiadou E; Yovos JG; Romeo G; McKay J; Lesueur F; Bonora E
Thyroid; 2005 Dec; 15(12):1349-54. PubMed ID: 16405407
[TBL] [Abstract][Full Text] [Related]
22. Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment.
Musholt TJ; Musholt PB; Petrich T; Oetting G; Knapp WH; Klempnauer J
World J Surg; 2000 Nov; 24(11):1409-17. PubMed ID: 11038215
[TBL] [Abstract][Full Text] [Related]
23. Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome.
Malchoff CD; Sarfarazi M; Tendler B; Forouhar F; Whalen G; Joshi V; Arnold A; Malchoff DM
J Clin Endocrinol Metab; 2000 May; 85(5):1758-64. PubMed ID: 10843148
[TBL] [Abstract][Full Text] [Related]
24. RE: HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer.
Carvajal-Carmona LG; Tomlinson I; Sahasrabudhe R
J Natl Cancer Inst; 2016 Aug; 108(8):. PubMed ID: 27154966
[No Abstract] [Full Text] [Related]
25. Targeted next-generation sequencing in papillary thyroid carcinoma patients looking for germline variants predisposing to the disease.
Shen CT; Zhang GQ; Qiu ZL; Song HJ; Sun ZK; Luo QY
Endocrine; 2019 Jun; 64(3):622-631. PubMed ID: 30826992
[TBL] [Abstract][Full Text] [Related]
26. A gene-disease association study of IL18 in thyroid cancer: genotype and haplotype analyses.
Abdolahi F; Dabbaghmanesh MH; Haghshenas MR; Ghaderi A; Erfani N
Endocrine; 2015 Dec; 50(3):698-707. PubMed ID: 26041375
[TBL] [Abstract][Full Text] [Related]
27. The G534E variant in HABP2 is not associated with increased risk of familial nonmedullary thyroid cancer in Brazilian Kindreds.
de Mello LEB; Araujo AN; Alves CX; de Paiva FJP; Brandão-Neto J; Cerutti JM
Clin Endocrinol (Oxf); 2017 Jul; 87(1):113-114. PubMed ID: 28418605
[No Abstract] [Full Text] [Related]
28. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
[TBL] [Abstract][Full Text] [Related]
29. Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.
Jendrzejewski J; Liyanarachchi S; Eiterman A; Thomas A; He H; Nagy R; Senter L; Sworczak K; de la Chapelle A
Int J Cancer; 2019 Feb; 144(3):503-512. PubMed ID: 30350351
[TBL] [Abstract][Full Text] [Related]
30. Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer.
Capezzone M; Cantara S; Marchisotta S; Busonero G; Formichi C; Benigni M; Capuano S; Toti P; Pazaitou-Panayiotou K; Caruso G; Carli AF; Palummo N; Pacini F
J Clin Endocrinol Metab; 2011 Nov; 96(11):E1852-6. PubMed ID: 21865371
[TBL] [Abstract][Full Text] [Related]
31. 1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: correlation with histological variants and clinical parameters.
Dardano A; Falzoni S; Caraccio N; Polini A; Tognini S; Solini A; Berti P; Di Virgilio F; Monzani F
J Clin Endocrinol Metab; 2009 Feb; 94(2):695-8. PubMed ID: 19017759
[TBL] [Abstract][Full Text] [Related]
32. Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients.
Capezzone M; Cantara S; Marchisotta S; Filetti S; De Santi MM; Rossi B; Ronga G; Durante C; Pacini F
J Clin Endocrinol Metab; 2008 Oct; 93(10):3950-7. PubMed ID: 18664542
[TBL] [Abstract][Full Text] [Related]
33. Germline compound heterozygous poly-glutamine deletion in USF3 may be involved in predisposition to heritable and sporadic epithelial thyroid carcinoma.
Ni Y; Seballos S; Fletcher B; Romigh T; Yehia L; Mester J; Senter L; Niazi F; Saji M; Ringel MD; LaFramboise T; Eng C
Hum Mol Genet; 2017 Jan; 26(2):243-257. PubMed ID: 28011713
[TBL] [Abstract][Full Text] [Related]
34. [Biological characteristics and management of familial papillary thyroid carcinoma].
Zhao J; Yu Y; Xia TT; Liu YZ; Wei SF; Zheng XQ; Gao M
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Nov; 46(11):897-900. PubMed ID: 22335974
[TBL] [Abstract][Full Text] [Related]
35. Familial non-medullary thyroid carcinoma: an update.
Nosé V
Endocr Pathol; 2008; 19(4):226-40. PubMed ID: 18931957
[TBL] [Abstract][Full Text] [Related]
36. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.
Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B
Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298
[TBL] [Abstract][Full Text] [Related]
37. SIN1, a critical component of the mTOR-Rictor complex, is overexpressed and associated with AKT activation in medullary and aggressive papillary thyroid carcinomas.
Moraitis D; Karanikou M; Liakou C; Dimas K; Tzimas G; Tseleni-Balafouta S; Patsouris E; Rassidakis GZ; Kouvaraki MA
Surgery; 2014 Dec; 156(6):1542-8; discussion 1548-9. PubMed ID: 25456951
[TBL] [Abstract][Full Text] [Related]
38. Telomere abnormalities and chromosome fragility in patients affected by familial papillary thyroid cancer.
Cantara S; Pisu M; Frau DV; Caria P; Dettori T; Capezzone M; Capuano S; Vanni R; Pacini F
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1327-31. PubMed ID: 22539583
[TBL] [Abstract][Full Text] [Related]
39. Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications.
Joung JY; Kim TH; Jeong DJ; Park SM; Cho YY; Jang HW; Jung YY; Oh YL; Yim HS; Kim YL; Chung JH; Ki CS; Kim SW
Histopathology; 2016 Jul; 69(1):45-53. PubMed ID: 26568156
[TBL] [Abstract][Full Text] [Related]
40. Familial papillary thyroid carcinoma is genetically distinct from familial adenomatous polyposis coli.
Malchoff CD; Sarfarazi M; Tendler B; Forouhar F; Whalen G; Malchoff DM
Thyroid; 1999 Mar; 9(3):247-52. PubMed ID: 10211600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
